CAS: 558447-26-0
Marchio | Dati del prodotto | Purezza | Fascia di prezzo | Consegna prevista |
---|---|---|---|---|
AMD 070 REF: IN-DA00DB4PCAS: 558447-26-0 | % | 166,00 €~604,00 € | Mar 07 Gen 25 | |
(S)-N1-((1H-Benzo[d]imidazol-2-yl)methyl)-N1-(5,6,7,8-tetrahydroquinolin-8-yl)butane-1,4-diamine REF: 3D-IXA44726CAS: 558447-26-0 | Min. 95 Area-% | 136,00 €~588,00 € | Lun 27 Gen 25 | |
Mavorixafor REF: TM-TQ0174CAS: 558447-26-0 | 98.56% | 69,00 €~816,00 € | Lun 24 Feb 25 | |
(S)-N1-((1H-Benzo[d]imidazol-2-yl)methyl)-N1-(5,6,7,8-tetrahydroquinolin-8-yl)butane-1,4-diamine REF: 10-F229693CAS: 558447-26-0 | 97.0% | - - - | Prodotto fuori produzione |
(S)-N1-((1H-Benzo[d]imidazol-2-yl)methyl)-N1-(5,6,7,8-tetrahydroquinolin-8-yl)butane-1,4-diamine
CAS:558447-26-0
(S)-N1-((1H-Benzo[d]imidazol-2-yl)methyl)-N1-(5,6,7,8-tetrahydroquinolin-8-yl)butane-1,4-diamine is an activated molecule that has been shown to be effective in the treatment …
Formula:
C21H27N5
Purezza:
Min. 95 Area-%
Colore e forma:
Powder
Peso molecolare:
349.48 g/mol
Ref: 3D-IXA44726
1mg | 136,00 € | ||
2mg | 192,00 € | ||
5mg | 271,00 € | ||
10mg | 406,00 € | ||
25mg | 588,00 € |
Consegna stimata in Stati Uniti, il Lunedì 27 Gennaio 2025
Mavorixafor
CAS:558447-26-0
Mavorixafor (AMD-070) is an effective and selective antagonist of CXCR4, with an IC50 value of …
Formula:
C21H27N5
Purezza:
98.56%
Colore e forma:
Solid
Peso molecolare:
349.47
Ref: TM-TQ0174
1mg | 69,00 € | ||
2mg | 90,00 € | ||
5mg | 150,00 € | ||
10mg | 216,00 € | ||
25mg | 387,00 € | ||
50mg | 575,00 € | ||
100mg | 816,00 € | ||
1mL*10mM (DMSO) | 248,00 € |
Consegna stimata in Stati Uniti, il Lunedì 24 Febbraio 2025
(S)-N1-((1H-Benzo[d]imidazol-2-yl)methyl)-N1-(5,6,7,8-tetrahydroquinolin-8-yl)butane-1,4-diamine
CAS:558447-26-0
Purezza:
97.0%
Peso molecolare:
349.48199462890625
Ref: 10-F229693
250mg | Fuori produzione | Richiedi informazioni |